Autobahn Therapeutics has announced a significant milestone in its development of elunetirom, a novel central nervous system (CNS)-directed thyroid hormone…
Read More
Blood-Based Epigenetic Markers of Immune Cell Aging Reveal New Pathways for Identifying Depression Symptoms
A landmark study published in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences has unveiled a significant…
Read More
Blood-Based Epigenetic Markers of Immune Cell Aging Reveal New Pathways for Precision Depression Diagnosis and Treatment
The landscape of psychiatric medicine is undergoing a fundamental shift as researchers move away from purely symptomatic assessments toward objective…
Read More
Advanced Blood Analysis of Immune Cell Aging Offers New Pathway for Objective Depression Diagnosis and Precision Mental Health Care
The landscape of psychiatric medicine is undergoing a significant shift as researchers move closer to replacing subjective symptom reporting with…
Read More
McGill University Researchers Identify Specific Brain Cells Linked to Depression in Landmark Study
A groundbreaking study led by researchers at McGill University and the Douglas Research Centre has fundamentally altered the scientific understanding…
Read More
First Phase 3 psilocybin data clears the bar for treatment-resistant depression, but how high was the bar?
For decades, successive waves of antidepressants have promised relief to millions suffering from mood disorders, yet the landscape for those…
Read More
MRI scans show body-focused mind wandering may reduce symptoms of ADHD and depression
New research published in the Proceedings of the National Academy of Sciences on March 25 suggests that when individuals’ minds…
Read More
First Phase 3 psilocybin data clears the bar for treatment-resistant depression, but how high was the bar?
For decades, the medical community has grappled with the persistent challenge of mood disorders, offering successive waves of antidepressants that,…
Read More
First Phase 3 psilocybin data clears the bar for treatment-resistant depression, but how high was the bar?
The landscape of mental health treatment witnessed a significant development on February 17, 2026, as Compass Pathways, a leading mental…
Read More
Researchers Identify Cellular Energy Deficits as Key Biological Marker for Early Stage Major Depression
In a collaborative breakthrough that may redefine the clinical understanding of psychiatric disorders, researchers from the University of Queensland and…
Read MoreYOU MAY HAVE MISSED
